Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up

Medical Science Monitor

Volumn 17, Issue 1, 2011, Pages

  Krecki, Radosław ^a   Krzemińska Pakuła, Maria ^a   Peruga, Jan Z ^a   Szcześniak, Piotr ^a   Lipiec, Piotr ^a   Wierzbowska Drabik, Karina ^a   Orszulak Michalak, Daria ^a   Kasprzak, Jarosław D ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiogenesis; Dipocytokines; Multivessel coronary heart diseasea; Prognosis

Indexed keywords

ADIPONECTIN; ANGIOGENIN; RESISTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PANCREATIC RIBONUCLEASE;

ADULT; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; STROKE; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EXERCISE TEST; GLUCOSE TOLERANCE; HEART ATRIUM FIBRILLATION; KIDNEY FAILURE; METABOLIC EQUIVALENT; Q WAVE; ST SEGMENT DEPRESSION; AGED; BLOOD; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ARREST; MIDDLE AGED; NONPARAMETRIC TEST; POLAND; PROGNOSIS;

ADIPONECTIN; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; POLAND; PROGNOSIS; RESISTIN; RIBONUCLEASE, PANCREATIC; STATISTICS, NONPARAMETRIC; STROKE;

EID: 78651402715     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881325     Document Type: Article

References (31)

1. American Heart Association. Heart Disease and Stroke Statistics - 2008 Update. American Heart Association, Dallas, Texas 2008
2. Morrow A, Gersh J, Braunwald E: Chronic Coronary Hart Disease [In:] Zipes DR, Libby P, Bonow RO, Braunwald E (eds.). Braunwald's Heart Disease - a textbook of cardiovascular medicine 7th Edition. 2005; 50: 1281-354
3. Solomon AJ, Gersh BJ: Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty and coronary artery bypass surgery. Lessons from the randomized trials. Ann Intern Med, 1998; 128: 216-23
4. Ouchi N, Kihara S, Arita Y et al: Novel modulator for endothelial adhesion molecules: Adipocytederived plasma protein adiponectin. Circulation, 1999; 100: 2473-76
5. Koenig W, Khuseyinova N, Baumert J et al: Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle aged men: results from the 18-years follow-up of a large cohort from southern Germany. J Am Coll Cardiol, 2006; 48: 1369-77
6. Nakamura Y, Shimada K, Fukuda D et al: Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart, 2004; 90: 528-33
7. Piestrzeniewicz K, Luczak K, Maciejewski M, Goch JH: Impact of obesity and adipokines on cardiac structure and function in men with first myocardial infarction. Arch Med Sci, 2008; 4(2): 152-60
8. Cavusoglu E, Ruwende C, Chopra V et al: Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J, 2006; 27: 2300-9
9. Laughlin GA, Barrett-Connor E, May S, Langenberg C: Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol, 2007; 165: 164-74
10. Steppan CM, Brown EJ, Wright CM et al: A family of tissue specific resistin- like molecules. Proc Natl Acad Sci, 2001; 98: 502-6
11. Ohmori R, Momiyama Y, Kato R et al: Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol, 2005; 46: 379-90
12. Verma S, Li SH, Wang CH et al: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation, 2003; 108: 736-40
13. Burnett MS, Lee CW, Kinnaird TD et al: The potential role of resistin in atherogenesis. Atherosclerosis, 2005; 182: 241-48
14. Weikert C, Westphal S, Berger K et al: Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab, 2008; 93: 2647-53
15. Piestrzeniewicz K, Luczak K, Goch JH: Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction. Neuro Endocrinol Lett, 2008; 29: 581-88
16. Tabibiazar R, Rockson SG: Angiogenesis and the ischaemic heart. Eur Heart J, 2001; 22: 903-18
17. Khurana R, Simons M, Martin FJ, Zachary IC: Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal. Circulation, 2005; 112: 1813-24
18. Moreno PR, Purushothaman KR, Fuster V et al: Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation, 2004; 110: 2032-38
19. Tello-Montoliu A, Marín F, Patel J et al: Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. Eur Heart J, 2007; 28: 3006-11
20. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/ AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal Definition of Myocardial Infarction. Circulation, 2007; 116: 2634-53
21. Reilly MP, Lehrke M, Wolfe ML et al: Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 2005; 111: 932-39
22. Hu WL, Qiao SB, Hou Q, Yuan JS: Plasma resistin is increased in patients with unstable angina. Chin Med J, 2007; 120: 871-75
23. Lubos E, Messow CM, Schnabel R et al: Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis, 2007; 193: 121-28
24. Inoue T, Kotooka N, Morooka T et al: High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol, 2007; 100: 569-74
25. Pischon T, Girman CJ, Hotamisligil GS et al: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 2004; 291: 1730-37
26. Tamura T, Furukawa Y, Taniguchi R et al: Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J, 2007; 71: 623-30
27. George J, Patal S, Wexler D et al: Circulating adiponectin concentrations in patients with congestive heart failure. Heart, 2006; 92: 1420-24
28. Werner SG, Jandt E, Krack A et al: Occlusions: Relation to Duration of Occlusion and Collateral Function Growth Factors in the Collateral Circulation of Chronic Total Coronary. Circulation, 2004; 110: 1940-45
29. Moulton KS, Heller E, Konerding MA et al: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E - deficient mice. Circulation, 1999; 99: 1726-32
30. Tenaglia AN, Peters KG, Sketch MH Jr, Annex BH: Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am Heart J, 1998; 135: 10-14
31. Kwon HM, Sangiorgi G, Ritman EL et al: Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol, 1998; 32: 2072-79